- https://www.novartis.com/stories/getting-down-roots-alzheimers-disease
Experimental treatments for Alzheimer’s disease put the amyloid cascade hypothesis to the test.
- https://www.novartis.com/stories/prioritizing-needs-patients
- https://www.novartis.com/stories/going-global-meet-local-needs-china
Marc Pelletier traveled from Cambridge, MA to Shanghai, China, to launch new lines of research for the treatment of cancers that are common in China.
- https://www.novartis.com/stories/how-love-sport-led-scientific-breakthrough
Jeff Weers’ passion inspired a new way of getting inhaled medicine past the body’s natural defenses to reach the lungs.
- https://www.novartis.com/stories/heart-failure-leading-cause-hospitalizations-it-doesnt-have-be
For all too many people living with heart failure, hospitalizations are a recurring part of life, affecting the lives of both patients and their caregivers.
- https://www.novartis.com/stories/eye-patients-mind-innovation
New Global Head of Ophthalmology Research sees the eye as a frontier of biomedical research.
- https://www.novartis.com/stories/helping-clinical-trial-patients-during-lockdown
Yan Zhao talks about how her team in China responded to an emerging public health crisis.
- https://www.novartis.com/stories/how-scientists-aim-expand-immunotherapy-options-cancer-patients
Read how NIBR and Dana-Farber scientists aim to expand immunotherapy options for patients
- https://www.novartis.com/stories/immuno-oncology-researchers-seek-build-smart-drug-combos
Novartis has launched a comprehensive research program to help find the right combinations of therapies for the right patients.
- https://www.novartis.com/stories/innovating-trusted-class-antibiotics-attack-superbugs
A new compound aims to attack dangerous antibiotic-resistant bacteria.
Pagination
- ‹ Previous page
- 1
- …
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- …
- 38
- › Next page